Enabling flexible and cost-saving manufacturing for life-saving biologic therapies.
Chromatan is commercializing a new purification platform to de-bottleneck large-scale manufacturing of life-saving biologics . We have shown up to 15-fold improvements and 65% cost reduction in multiple pilot studies with large biotechs like Merck and Regeneron.
In 2017 ChromaTan was awarded a $2.5 Million contract from the FDA. We are raising $1.1 Million to enable manufacturing, scale-up and sales of our process development system.